LOGO
LOGO

WuXi PharmaTech Q3 Profit Rises; Reconfirms FY09 Revenue Outlook - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

WuXi PharmaTech (Cayman) Inc. (WX) reported GAAP net income of $14.3 million or $0.19 per ADS, compared to $7.3 million or $0.10 per ADS for the year-ago quarter.

Income from continuing operations for the third quarter was $14.5 million or $0.19 per ADS, compared to $8.4 million or $0.12 per ADS in the prior year quarter.

Non-GAAP operating income for the third quarter was $17.6 million or $0.24 per ADS, compared to $13.2 million or $0.18 per ADS in the third quarter of last year.

Net revenues for the quarter grew 10% to $70.04 million from $63.79 million in the same quarter last year.

Analysts polled by Thomson Reuters expected the company to earn $0.15 per share on revenue of $70.22 million for the third quarter.

The company reconfirmed its expectation for 2009 total net revenues of $265 million to $275 million. Analysts currently expect the company to post revenue of $269.49 million for the full year 2009.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.